Visceral Fat and Metabolic Risk: Why Location Matters More Than Total
Two people walk into a clinic. Same height, same weight, same body fat percentage, same age, same sex. One has roughly three times the metabolic risk of the other.
The difference is where the fat is stored, and body fat percentage cannot see it.
What visceral fat actually is
Fat is stored in two structurally different places.
Subcutaneous fat sits between skin and muscle. It is what you can pinch. It is the fat that calipers measure and the fat that changes how you look.
Visceral fat sits inside the abdominal cavity, wrapped around and between the organs: liver, intestines, pancreas. You cannot pinch it, you cannot see it, and it behaves differently from subcutaneous fat.
The behavioural difference is the point. Visceral adipose tissue is metabolically active in a way subcutaneous fat is not. It drains directly into the portal vein, delivering free fatty acids and inflammatory signalling molecules straight to the liver rather than into general circulation. That is the mechanistic argument for why the same kilogram of fat carries different risk depending on where it sits.
The evidence that location beats total
The Multi-Ethnic Study of Atherosclerosis followed participants who were free of clinical cardiovascular disease at enrolment, with CT measured visceral and subcutaneous fat. The final analysis population for visceral adiposity measures was 1,511 individuals (Shah et al., Journal of the American College of Cardiology).
Over a median follow up of 6.2 years, 203 of 862 participants who were free of metabolic syndrome at baseline developed it, which is 24 per cent.
Measure | Hazard ratio for incident metabolic syndrome | 95% confidence interval |
Visceral fat, unadjusted, per 100 cm²/m | 1.31 | 1.24 to 1.39 |
Visceral fat, fully adjusted, per 100 cm²/m | 1.28 | 1.17 to 1.40 |
Subcutaneous fat, unadjusted, per 100 cm²/m | 1.16 | 1.12 to 1.20 |
Visceral fat carried the higher risk, and critically it retained almost all of its predictive power after adjustment for age, sex, race, weight, smoking status and the existing metabolic syndrome risk factors. Adjusting for total body weight did not explain it away.
Now the finding that matters most, because it is the one that catches people out. The study reported baseline metabolic syndrome prevalence broken down by both BMI category and visceral fat category.
Group | Metabolic syndrome prevalence |
Normal weight, low visceral fat | 9.3% |
Normal weight, high visceral fat | 27.6% |
Overweight, low visceral fat | 21.4% |
Overweight, high visceral fat | 41.4% |
Obese, low visceral fat | 38.8% |
Obese, high visceral fat | 64.0% |
A normal weight person with high visceral fat had a higher prevalence of metabolic syndrome than an overweight person with low visceral fat. Read those two rows again: 27.6% versus 21.4%.
This is the population sometimes described as normal weight but metabolically unhealthy. Their BMI is fine. Their scale is fine. Often their body fat percentage is unremarkable. Their risk is not.
What DEXA reports, and what the thresholds look like
A DEXA scan quantifies visceral adipose tissue in the android region, reported as a mass in grams and a volume in cubic centimetres. This is the same measurement in principle as the CT-derived figure, obtained at a fraction of the radiation dose.
A 2025 cross-sectional study measured DXA derived visceral adipose tissue in 301 urban adults, 147 men and 154 women, mean age 49.3 years, and derived thresholds for predicting metabolic syndrome (DXA visceral adipose tissue reference values).
Men | Women | |
Median VAT mass | 1,364 g | 1,060 g |
Threshold predicting metabolic syndrome | 1,369 g or above | 1,082 g or above |
Sensitivity at threshold | 86.2% | 76.3% |
Specificity at threshold | 74.2% | 76.9% |
Area under ROC curve | 0.868 (95% CI 0.811 to 0.924) | 0.855 (95% CI 0.798 to 0.912) |
An area under the curve above 0.85 is strong discrimination for a single measurement.
The same study tracked visceral fat by age group. In men, median VAT mass rose from 366 g in the 18 to 30 bracket to 1,730 g in the 40 to 50 bracket. In women it rose from 567 g to 959 g across the same brackets. Visceral fat increased with age up to 70 in men and up to 60 in women.
Two honest caveats. This cohort was drawn from an urban population in Tlemcen, Algeria, with a high prevalence of metabolic disease at baseline, including 44.5 per cent with metabolic syndrome. Thresholds derived in one population do not transfer perfectly to another. And DXA estimates visceral fat from a model applied to the android region rather than imaging it directly as CT does, so the absolute figures differ between modalities.
Use the thresholds as a reference band, not a diagnosis. Use your own change over time as the more reliable signal.
Why body fat percentage is not enough
Body fat percentage is a single ratio of fat mass to total mass. It tells you how much fat you carry. It says nothing about where.
Two people at 22 per cent body fat can have materially different visceral fat masses, and the MESA data says their risk profiles differ accordingly. Methods that estimate body fat from skinfolds or impedance are even further removed, because they infer total fat from peripheral measurements and cannot distinguish the compartments at all.
This is the specific reason a DEXA scan reports visceral fat separately rather than folding it into one percentage. It is a different number with a different meaning.
What moves it
The reassuring part. Visceral fat is responsive.
An energy deficit. Visceral fat responds to overall fat loss, and in many studies it responds proportionally faster than subcutaneous fat in the early phase of weight loss.
Aerobic exercise, independent of weight loss.
Resistance training, which also protects the lean mass that supports your resting metabolic rate.
Reduced alcohol intake, which has a specific relationship with hepatic and visceral fat.
Sleep and stress management, both of which influence cortisol and abdominal fat distribution.
There is no targeted exercise for it. Abdominal exercises do not preferentially reduce abdominal fat. What works is the unglamorous combination above, held long enough to show up on a rescan.
Common questions
Can I be lean and still have high visceral fat? Yes, and the MESA data quantifies it. Normal weight participants with high visceral fat had a 27.6 per cent prevalence of metabolic syndrome, three times the 9.3 per cent in normal weight participants with low visceral fat.
How much radiation is in a DEXA scan? Very low, and substantially lower than a CT scan of the abdomen. It is the reason DEXA is viable for repeat measurement and CT generally is not.
How often should I rescan? Every 8 to 12 weeks during an active phase, or every 6 months for monitoring. Visceral fat does not change meaningfully in a fortnight.
Does a waist measurement tell me the same thing? Partly. Waist circumference correlates with visceral fat but combines it with subcutaneous fat and cannot separate the two. It is a useful free proxy and a poor substitute for the measurement.
The short version
Visceral fat sits around your organs, drains into the liver, and carries higher metabolic risk per unit than subcutaneous fat. In the MESA cohort it predicted incident metabolic syndrome with a hazard ratio of 1.28 per 100 cm²/m even after adjustment for weight and existing risk factors. Normal weight people with high visceral fat had three times the metabolic syndrome prevalence of normal weight people with low visceral fat. Body fat percentage cannot see any of this. A DEXA scan reports it as its own number.
A DEXA scan at Precision Body Lab is $149 for an initial scan and $99 for a follow up. Book online or call 1300 910 163.
Related reading
Sources
Shah RV, Murthy VL, Abbasi SA, et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA study. Journal of the American College of Cardiology. https://pmc.ncbi.nlm.nih.gov/articles/PMC4268163/
Reference values and metabolic syndrome thresholds for DXA-derived visceral adipose tissue in an adult population, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12419631/
Müller MJ, Bosy-Westphal A. Adaptive thermogenesis with weight loss in humans. Obesity, 2013. https://onlinelibrary.wiley.com/doi/full/10.1002/oby.20027
Comments